扩大肯尼亚严重急性营养不良 (SAM) 治疗的覆盖范围 (R-SWITCH)
评估授权社区健康促进者通过家庭主导的 MUAC 扩大、年龄体重筛查和违约者随访来提高图尔卡纳县消瘦治疗覆盖率的影响、实施和成本
Child wasting is a type of malnutrition which occurs when a child becomes too thin. This medical condition increases the risk of becoming sick or dying. A child with severe wasting needs to be seen in a medical consultation to check on health status and to receive some medicine and a medical food supplement for daily consumption until cured. Yet, only a small proportion of children suffering from severe wasting are presently receiving appropriate treatment.
In Kenya, there is an opportunity to build on the existing network of community health promoters (CHPs) to increase the number of children with wasting who are identified and treated. In intervention areas, CHPs will be equipped with smartphones and an application which provides guidance on household members to visit and simple actions to take, related to health. CHPs will distribute color-coded mid-upper arm circumference tapes to households with young children and train caregivers on how to use it. After training, CHPs will send Short Message Services (SMS) to remind caregivers to regularly measure the arm circumference of the child. In addition, CHPs will receive a scale to measure the weight of children every month. Finally, wasted children registered in the treatment program who fail to attend a planned consultation will be flagged to their CHP through the phone application, and CHPs will conduct a specific home visit to investigate and help solve potential issues.
The study will assess whether this community intervention (called SWITCH) allows to identify and treat more children suffering from severe wasting. Before the start of the intervention, the proportion of wasted children receiving treatment in 40 community units in Turkana South, Turkana East and Aroo will be assessed. After this survey, a computer will randomly select 20 community units where the intervention will be scaled up. The survey will be repeated after 2 years to assess if the proportion of severely wasted children receiving treatment is higher in the area where the intervention was scaled up compared to the area where it was not scaled up.
In addition, after 1 year of implementation, the study will assess how the intervention was scaled up, what are the main challenges, and what are the overall perceptions on the intervention in the community among those who receive it and those who deliver it. Finally, costs of the various components of the intervention will be measured for all actors involved, including for caregivers.
研究概览
详细说明
Despite the burden and impact of child wasting on morbidity and mortality, only a small proportion of severely wasted children are presently receiving treatment. In Kenya, there is an opportunity to strengthen the screening for wasting and the identification and treatment of wasted children (SWITCH) through community health promoters (CHPs) who, per policy, are trained, equipped, incentivized and supervised by community health agents (CHAs).
An intervention package will be implemented including: 1) Digitization to support CHPs, 2) Family-led Mid-Upper Arm Circumference (MUAC) enhanced by digitization, with a two-way messaging platform between CHP and caregivers, and reminders for timely training at 6 months of age, 3) Equipment of CHPs with a baby-mother scale for measurement of weight-for-age to detect likely wasting, and 4) Real-time follow-up in the community (facilitated by digitization) of defaulters and non-respondent children enrolled for wasting treatment.
A randomized controlled trial will be used to assess the impact of the SWITCH intervention on severe wasting treatment coverage in Turkana. Twenty randomly selected community units of 40 will receive the intervention. An exhaustive screening campaign conducted at baseline and endline (after 2 years) in the 40 community units will identify children with severe wasting (MUAC < 115 mm or Weight-for-Height Z-score < -3 or bilateral pitting oedema) or recovering from severe wasting (defined by receipt and consumption of Ready-to-Use Therapeutic Food), who will be enrolled in a survey assessing treatment coverage, program exposure and other pathways to impact, and confounders.
In addition, the study will assess the reach, adoption by CHPs, and implementation challenges of the SWITCH package through additional qualitative (interviews and observations) and quantitative data collection at all levels of program delivery (beneficiaries, CHPs, CHAs, program implementers); and the unit cost of the SWITCH package per beneficiary (and cost-effectiveness if the package is effective) through an activity-based costing-ingredients approach.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Lodwar、肯尼亚
- Turkana South and Turkana East and Aroo
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
-
Household in a village of the study area covered by a CHP (although the child may or may not be registered by a CHP) AND
-
Child is 6-59.9 months of age AND
-
Caregiver consents to be part of the study AND
-
any of the following:
- WHZ < -3 (relative to WHO 2006 reference) OR
- MUAC <115 mm OR
- Presence of bilateral edema OR
- receiving treatment as follow-up for an initial SAM condition on the way to full recovery
exclusion criteria is:
- Congenital malformation that makes anthropometric measurements impossible.
- Length is below 54 cm or height is above 120cm.
学习计划
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
无干预:Standard of Care
|
|
|
实验性的:SWITCH intervention package
|
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Period prevalence of severe wasting (SAM) treatment coverage in children 6-59 months of age
大体时间:After 24 months of program implementation
|
defined as the proportion of children suffering from SAM or recovering from SAM who currently receive treatment. • SAM defined by weight-for-height Z-score (WHZ) <-3 (relative to World Health Organization (WHO) 2006 reference) or MUAC <115 mm or by the presence of bilateral edema. Children recovering from SAM through treatment will be considered to receive treatment for an initial SAM condition if they both attended an IMAM consultation in the previous 15 days (as reported by caregiver OR by a consultation card) AND either:
|
After 24 months of program implementation
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Mean weight-for-height Z-score (WHZ)
大体时间:After 24 months of program implementation
|
In 6-59 months old children.To calculate WHZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Mean mid-upper arm circumference (MUAC)
大体时间:After 24 months of program implementation
|
In 6-59 months old children. |
After 24 months of program implementation
|
|
Point prevalence of SAM outpatient therapeutic program (OTP) treatment coverage in children 6-59 months of age
大体时间:After 24 months of program implementation
|
Defined as the proportion of children with SAM at the time of the survey that are under treatment (see definition under primary outcome) |
After 24 months of program implementation
|
|
Screening coverage of SAM
大体时间:After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months suffering from SAM ((currently or on their way to recovery from SAM through treatment for an initial SAM condition) ) screened for wasting over the last 30 days (as reported by the caregiver) |
After 24 months of program implementation
|
|
Prevalence of SAM
大体时间:After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with SAM (defined as WHZ <-3 (relative to World Health Organization (WHO) 2006 reference) or a MUAC < 115 mm or the presence of bilateral pitting edema). Also calculated on the restricted population of children aged 6-59 months suffering or recovering from SAM (same definition as for primary outcome) |
After 24 months of program implementation
|
|
Prevalence of very low WHZ
大体时间:After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with WHZ <-3 (relative to World Health Organization (WHO) 2006 reference). |
After 24 months of program implementation
|
|
Prevalence of very low MUAC
大体时间:After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with MUAC<115 mm |
After 24 months of program implementation
|
|
Prevalence of moderate acute malnutrition (MAM)
大体时间:After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with MAM (defined as -3<= WHZ <-2 (relative to World Health Organization (WHO) 2006 reference) or 115<= MUAC < 125 mm). Also calculated on the restricted population of children aged 6-59 months suffering or recovering from SAM (same definition as for primary outcome) |
After 24 months of program implementation
|
|
Prevalence of wasting
大体时间:After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with wasting (defined as WHZ <-2 (relative to World Health Organization (WHO) 2006 reference) or a MUAC < 125 mm or the presence of bilateral pitting edema). Also calculated on the restricted population of children aged 6-59 months suffering or recovering from SAM (same definition as for primary outcome) |
After 24 months of program implementation
|
|
Prevalence of stunting
大体时间:After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months suffering from SAM or recovering from SAM with stunting (defined as height-for-age Z-scores (HAZ) <-2 or a MUAC < 125 mm or the presence of bilateral pitting edema). To calculate HAZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Prevalence of underweight and severe underweight
大体时间:After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months suffering from SAM or recovering from SAM with underweight (defined as weight-for-age Z-scores (WAZ) <-2 ) and severe underweight (defined as WAZ <-3 ). To calculate WAZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Mean height-for-age Z-score (HAZ)
大体时间:After 24 months of program implementation
|
In 6-59 months old children suffering from SAM or recovering from SAM. Scores will be calculated relative to World Health Organization (WHO) 2006 reference, with a higher score meaning a better outcome |
After 24 months of program implementation
|
|
Mean weight-for-age Z-score (WAZ)
大体时间:After 24 months of program implementation
|
In 6-59 months old children suffering from SAM or recovering from SAM. To calculate WAZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Caregiver's knowledge score
大体时间:After 24 months of program implementation
|
The score will be calculated by adding one point for each right answer to a series of questions related to infant and child feeding, child health and hygiene, the condition of severe acute malnutrition, outpatient therapeutic programs, screening of wasting. Questions were specifically developed for the study based on program activities and asked to caregiver of children aged 6-59 months suffering from SAM or recovering from SAM |
After 24 months of program implementation
|
|
Prevalence of appropriate immunization
大体时间:After 24 months of program implementation
|
Proportion of children aged 6-18 months with SAM or enrolled in SAM OTP who received all recommended immunizations |
After 24 months of program implementation
|
|
Coverage of the integrated management of acute malnutrition (IMAM) platform
大体时间:After 24 months of program implementation
|
proportion of children aged 6-59 months suffering from SAM or recovering from SAM who attended an IMAM consultation in the previous 15 days (as reported by the caregiver or by an IMAM treatment card) |
After 24 months of program implementation
|
|
Coverage of the community unit platform
大体时间:After 24 months of program implementation
|
proportion of children aged 6-59 months suffering from SAM or recovering from SAM in contact with a CHP in the 2 months preceding the survey for community care-related matter (as reported by the caregiver) |
After 24 months of program implementation
|
|
Coverage of family MUAC
大体时间:After 24 months of program implementation
|
proportion of children aged 6-59 months suffering from SAM or recovering from SAM screened in the month preceding the survey by a family member using a MUAC tape (as reported by the caregiver) |
After 24 months of program implementation
|
|
Coverage of family MUAC training
大体时间:After 24 months of program implementation
|
proportion of children aged 6-59 months suffering from SAM or recovering from SAM for which at least one family member was trained to use MUAC tape (as reported by the caregiver) |
After 24 months of program implementation
|
|
Coverage of MUAC tapes
大体时间:After 24 months of program implementation
|
proportion of children aged 6-59 months suffering from SAM or recovering from SAM for which at least one family member owns a MUAC tape (as reported by the caregiver AND confirmed by observation) |
After 24 months of program implementation
|
|
Coverage of WAZ screening
大体时间:After 24 months of program implementation
|
proportion of children aged 6-59 months suffering from SAM or recovering from SAM weighed in the 2 months preceding the survey by a CHP or a health staff using a scale (as reported by the caregiver) |
After 24 months of program implementation
|
|
Period prevalence of wasting treatment coverage in children 6-59 months of age
大体时间:After 24 months of program implementation
|
Defined as the proportion of children suffering or recovering from wasting who currently receive treatment. • Wasting defined by weight-for-height Z-score (WHZ) <-2 (relative to World Health Organization (WHO) 2006 reference) or MUAC <125 mm or by the presence of bilateral edema. Children recovering from wasting will be considered to receive treatment if they both attended an IMAM consultation in the previous 15 days (as reported by caregiver OR by a consultation card) AND either: consumed RUTF at least once in the previous 3 days (as reported by the caregiver AND confirmed by observation of >= 1 full or 2 empty RUTF sachets) OR consumed RUSF at least once in the previous 3 days (as reported by the caregiver AND confirmed by observation by the enumerator of >= 1 full or 2 empty RUSF sachets) AND child does not suffer from SAM (as defined above) |
After 24 months of program implementation
|
合作者和调查者
调查人员
- 首席研究员:Elodie Becquey, PhD、International Food Policy Research Institute
- 首席研究员:Sophie Ochola, PhD、Kenyatta University
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- RSWITCH-Kenya
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
All data will be carefully anonymized and de-identified so that the privacy of participants and research subjects is fully protected. Databases will be anonymized using identification codes. No names, GPS coordinates, dates of birth or other identifying data will be stored in the databases.
At the time of publication of scientific articles presenting primary results, the fully anonymized databases (quantitative data) will become a public good and will be made available to the scientific community, government, and partners.
IPD 共享时间框架
At the time of publication of scientific articles presenting primary results.
IPD 共享支持信息类型
- 研究方案
- 树液
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.